Ablynx
Ablynx is a biopharmaceutical company specializing in the development of Nanobody-based therapeutic proteins for a range of human diseases. The company was founded in 2001 and currently operates as a subsidiary of the French multinational pharmaceutical company Sanofi.
Brand Identity Data
HQ Country
Belgium
HQ City
Ghent
Founded
2001
EU Headquartered
Yes
EU Manufactured
Yes
Stock Exchange
Private
Repair / Recycling
No
Ethical Certifications
None verified
Verified on July 22, 2026